Insider Trading History of Schwieterman William D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Schwieterman William D since 2009. The trader's CIK number is 1403961. At the time of the last reporting, Schwieterman William D was the Director of Mateon Therapeutics Inc. (stock ticker symbol MATN). Also see all insider trading activities at Mateon Therapeutics Inc.

Note that in the past Schwieterman William D also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Chelsea Therapeutics International, Ltd. (CHTP) by Schwieterman William D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CHTP 0 $0 0 $0 350,000 $1,051,050
2011 CHTP 85,141 $359,728 0 $0 0 $0
2009 CHTP 45,451 $117,200 0 $0 0 $0

Yearly summary of insider trading at Mateon Therapeutics Inc (MATN) by Schwieterman William D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 MATN 625,000 $0 0 $0 0 $0


Insider trading activities at 2 companies by Schwieterman William D:

1. Chelsea Therapeutics International, Ltd. (CHTP)

2. Mateon Therapeutics Inc (MATN)

Table 1. Insider trading of Chelsea Therapeutics International, Ltd. (CHTP) by Schwieterman William D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-06-23 CHTP Option Ex 350,000 3.00 1,051,050
2011-11-23 CHTP Buy 45,141 4.46 201,328
2011-03-07 CHTP Buy 40,000 3.96 158,400
2009-05-14 CHTP Buy 19,301 2.72 52,498
2009-05-13 CHTP Buy 11,150 2.48 27,652
2009-05-12 CHTP Buy 15,000 2.47 37,050

Table 2. Insider trading of Mateon Therapeutics Inc (MATN) by Schwieterman William D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-04-12 MATN Buy 625,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schwieterman William D (Director of Mateon Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.